Company intelligence / Profile preview
Combiphar
Padalarang, West Java, Indonesiacombiphar.com ↗
- Ownership
- Private
- Employees
- ~3383
- Development stage
- Other
01
Overview
Combiphar is a leading Indonesian pharmaceutical company with more than 150 prescription and over-the-counter products, exporting some to Australia, with capabilities in R&D, bioequivalence, and nanotechnology standards. It holds international certifications (ISO 14001:2004, TGA) and is recognized as a top national healthcare brand.
- Modalities
- Small moleculeBiologic
- Industry
- Biotech
02
Drug pipeline
9 assets8 more assets in the full pipeline.
Beyond the preview
Go deeper on Combiphar.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Combiphar.